X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (73) 73
Patent (23) 23
Book / eBook (7) 7
Web Resource (7) 7
Newspaper Article (2) 2
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
animals (28) 28
index medicus (25) 25
human necessities (23) 23
hygiene (23) 23
medical or veterinary science (23) 23
preparations for medical, dental, or toilet purposes (23) 23
chemistry (21) 21
metallurgy (21) 21
oncology (21) 21
organic chemistry (21) 21
steroids (21) 21
mice (20) 20
male (19) 19
beer (18) 18
biochemistry (18) 18
compositions thereof (18) 18
culture media (18) 18
enzymology (18) 18
female (18) 18
microbiology (18) 18
microorganisms or enzymes (18) 18
mutation or genetic engineering (18) 18
propagating, preserving or maintaining microorganisms (18) 18
spirits (18) 18
vinegar (18) 18
wine (18) 18
specific therapeutic activity of chemical compounds ormedicinal preparations (17) 17
cancer (16) 16
acyclic or carbocyclic compounds (13) 13
cell line, tumor (11) 11
tumors (11) 11
cancer cells (10) 10
research (9) 9
angiogenesis (8) 8
breast-cancer (8) 8
growth (8) 8
mice, inbred balb c (8) 8
analysis (7) 7
endosialin (7) 7
expression (7) 7
stem cells (7) 7
tumor (7) 7
xenograft model antitumor assays (7) 7
aged (6) 6
genetics & heredity (6) 6
in-vitro (6) 6
adult (5) 5
antineoplastic agents - pharmacology (5) 5
etiology (5) 5
health aspects (5) 5
medicine (5) 5
medicine, research & experimental (5) 5
metastasis (5) 5
middle aged (5) 5
neoplasms (5) 5
neoplasms - drug therapy (5) 5
neoplasms - pathology (5) 5
neoplastic stem cells (5) 5
progenitor cells (5) 5
proteins (5) 5
retrospective studies (5) 5
tumor microenvironment (5) 5
veterinary sciences (5) 5
angiogenesis inhibitors - pharmacology (4) 4
antigens, cd - metabolism (4) 4
cancer research (4) 4
care and treatment (4) 4
cells, cultured (4) 4
disease models, animal (4) 4
dogs (4) 4
endothelial growth-factor (4) 4
flow cytometry (4) 4
genetics (4) 4
mice, scid (4) 4
mutation (4) 4
neoplasms - blood supply (4) 4
pericytes (4) 4
pharmacology/toxicology (4) 4
placenta growth factor (4) 4
sarcoma (4) 4
tumor xenografts (4) 4
aged, 80 and over (3) 3
angiogenesis inhibitors - therapeutic use (3) 3
antigens, cd - genetics (3) 3
antigens, neoplasm - metabolism (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - therapeutic use (3) 3
biology (3) 3
biomedicine (3) 3
biotechnology & applied microbiology (3) 3
bone marrow cells - drug effects (3) 3
bone marrow cfu-gm (3) 3
breast neoplasms - pathology (3) 3
carcinogenesis (3) 3
dose-response relationship, drug (3) 3
electronic books (3) 3
endothelial cells - metabolism (3) 3
endothelial-cells (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 1. Aufl., Cancer drug discovery and development, ISBN 9781603279338, xv, 334 p., [12] p. of plates
The discovery of stem cells has ignited a field of discovery in many human disease areas including diabetes, neurology, and cancer. The tissues from which stem... 
Neoplastic Stem Cells | Clinical & internal medicine | Oncology | Pharmacology/Toxicology | Cancer Research | Biomedicine | Cancer cells | Stem cells | Cancer
Book
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 5032 - 5032
Introduction: gpNMB is an internalizable transmembrane protein overexpressed in 20 of breast cancers, 40 of triple-negative breast cancer (TNBC) and 80 of... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7_suppl, pp. 34 - 34
34 Background: TIM-1 (KIM-1, HAVcr-1) is a type 1 transmembrane glycoprotein. Expression is limited in healthy tissues but upregulated after kidney injury, in... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 1373 - 1373
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 28_suppl, pp. 129 - 129
129 Background: Glycoprotein NMB (gpNMB) is an internalizable transmembrane protein overexpressed in ~20% of BC. gpNMB promoted BC metastases in a murine model... 
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 4808 - 4808
Journal Article
International Journal of Oncology, ISSN 1019-6439, 02/2012, Volume 40, Issue 2, pp. 479 - 486
Journal Article
2010, Cancer drug discovery and development, ISBN 1441966145
Web Resource
2010, Cancer drug discovery and development, ISBN 1441966145
This book will explore the many biological and physical aspects of the tumor microenvironment. The book will include chapters on the various cells that... 
Physiology, Pathological | physiopathology | pathology | Growth | Cancer cells | Neoplastic Stem Cells | Metabolism | Carcinogenesis | Neoplasms | Tumors
Web Resource
Clinical Cancer Research, ISSN 1078-0432, 05/2011, Volume 17, Issue 9, pp. 2777 - 2787
PURPOSE: Genz-644282 [8,9-dimethoxy-5-(2-N-methylaminoethyl)-2,3-methylenedioxy-5H-dibe n zo[c,h][1,6]naphthyridin-6-one] has emerged as a promising candidate... 
Animal models
Journal Article
2010, 1. Aufl., ISBN 9781441966148
This book will explore the many biological and physical aspects of the tumor microenvironment. The book will include chapters on the various cells that... 
eBook
2010, Cancer drug discovery and development, ISBN 9781441966148, 764
This book explores the many biological and physical aspects of the tumor microenvironment. It represents a superb compilation of the latest thoughts and data... 
Clinical & internal medicine | Tumors | Tumors - Physiology, Pathological
eBook
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 11/2015, Volume 19, Issue 11, pp. 2564 - 2574
JAK2 inhibition therapy is used to treat patients suffering from myeloproliferative neoplasms (MPN). Conflicting data on this therapy are reported possibly... 
myeloproliferative neoplasms | preclinical murine models | fibrosis | JAK2 inhibitor | Preclinical murine models | Fibrosis | Myeloproliferative neoplasms | MYELOFIBROSIS | MEDICINE, RESEARCH & EXPERIMENTAL | JAK2(V617F) | POLYCYTHEMIA-VERA | MECHANISM | EFFICACY | RUXOLITINIB | CELL BIOLOGY | HEMATOPOIETIC-CELLS | MURINE MODEL | MUTATIONS | EXPRESSION | Thrombocythemia, Essential - drug therapy | Primary Myelofibrosis - drug therapy | Thrombocythemia, Essential - physiopathology | Splenomegaly - drug therapy | Primary Myelofibrosis - physiopathology | Polycythemia Vera - blood | Pyrrolidines - administration & dosage | Thrombocythemia, Essential - blood | Disease Progression | Primary Myelofibrosis - blood | Protein Kinase Inhibitors - administration & dosage | Animals | Platelet Count | Polycythemia Vera - drug therapy | Mice | Janus Kinase 2 - antagonists & inhibitors | Polycythemia Vera - physiopathology | Sulfonamides - administration & dosage | Transforming growth factors | Health aspects | Stem cells | Tumors | Spleen | Bone marrow | Rodents | Erythropoiesis | Splenomegaly | Therapy | Polycythemia vera | Kinases | Neoplasms | Blockage | Biomedical materials | Blood platelets | Polycythemia | Janus kinase 2 | Osteosclerosis | Inhibition | Phenotypes | Dysplasia | Myelofibrosis | Cytokines | Anemia | Progenitor cells | Mutation | Platelets | Original
Journal Article
Cancer, ISSN 0008-543X, 04/2019, Volume 125, Issue 7, pp. 1113 - 1123
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.